Firms ally to create platform for immunotherapy production

03/27/2013 | Genetic Engineering & Biotechnology News · RTT News

Sanofi and Transgene will invest $12.9 million to create a new industrial platform for immunotherapy production. The platform will belong to Sanofi. Sanofi and Genzyme will use the platform to manufacture clinical and commercial batches of Transgene's MVA1 therapeutic vaccines and other immunotherapy products.

View Full Article in:

Genetic Engineering & Biotechnology News · RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN